The emerging role of NETs in venousthrombosis and immunothrombosis

Frontiers in Immunology

Volumn 7, Issue JUN, 2016, Pages

  Kimball, Andrew S ^a   Obi, Andrea T ^a   Diaz, Jose A ^a   Henke, Peter K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Extracellular DNA; Immunothrombosis; NETs; Sepsis; Venous thromboembolism; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 12; CATHEPSIN G; CD18 ANTIGEN; CELL FREE DNA; DAMAGE ASSOCIATED MOLECULAR PATTERN RECEPTOR; DNA; EXTRACELLULAR DNA; GLYCOPROTEIN IB; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE H3; LEUKOCYTE ELASTASE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PHOSPHATIDYLSERINE; RECEPTOR; SERINE PROTEINASE; THROMBOCYTE FACTOR 4; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

CPG ISLAND; EXTRACELLULAR TRAP; IMMUNOTHROMBOSIS; INFECTION; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; MULTIPLE ORGAN FAILURE; MURINE MODEL; NEUTROPENIA; NONHUMAN; PATHOPHYSIOLOGY; PRIMATE MODEL; REVIEW; SEPSIS; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; THROMBUS; VEIN THROMBOSIS;

EID: 84977539401     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00236     Document Type: Review

References (86)

1. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science (2004) 303(5663):1532-5. doi:10.1126/science.1092385
2. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol (2007) 176(2):231-41. doi:10.1083/jcb.200606027
3. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A (2010) 107(36):15880-5. doi:10.1073/pnas.1005743107
4. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, et al. Extracellular histones are major mediators of death in sepsis. Nat Med (2009) 15(11):1318-21. doi:10.1038/nm.2053
5. Liaw PC, Ito T, Iba T, Thachil J, Zeerleder S. DAMP and DIC: the role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. Blood Rev (2016). doi:10.1016/j.blre.2015.12.004
6. Abrams ST, Zhang N, Manson J, Liu T, Dart C, Baluwa F, et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med (2013) 187(2):160-9. doi:10.1164/rccm.201206-1037OC
7. Demers M, Wagner DD. Neutrophil extracellular traps: a new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology (2013) 2(2):e22946. doi:10.4161/onci.22946
8. Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lämmle B. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood (2012) 120(6):1157-64. doi:10.1182/blood-2012-02-412197
9. Nakazawa D, Tomaru U, Yamamoto C, Jodo S, Ishizu A. Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis. Front Immunol (2012) 3:333. doi:10.3389/fimmu.2012.00333
10. Simon D, Simon HU, YousefiS. Extracellular DNA traps in allergic, infectious, and autoimmune diseases. Allergy (2013) 68(4):409-16. doi:10.1111/all.12111
11. He Z, Si Y, Jiang T, Ma R, Zhang Y, Cao M, et al. Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease. Thromb Haemost (2016) 115(4):738-51. doi:10.1160/TH15-09-0710
12. Jiménez-Alcázar M, Napirei M, Panda R, Köhler EC, Kremer Hovinga JA, Mannherz HG, et al. Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies. J Thromb Haemost (2015) 13(5):732-42. doi:10.1111/jth.12796
13. Gould TJ, Vu TT, Stafford AR, Dwivedi DJ, Kim PY, Fox-Robichaud AE, et al. Cell-free DNA modulates clot structure and impairs fibrinolysis in sepsis. Arterioscler Thromb Vasc Biol (2015) 35(12):2544-53. doi:10.1161/ATVBAHA.115.306035
14. Gould TJ, Lysov Z, Liaw PC. Extracellular DNA and histones: double-edged swords in immunothrombosis. J Thromb Haemost (2015) 13(S1):S82-91. doi:10.1111/jth.12977
15. Hirahashi J, Hishikawa K, Kaname S, Tsuboi N, Wang Y, Simon DI, et al. Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Circulation (2009) 120(13):1255-65. doi:10.1161/CIRCULATIONAHA.109.873695
16. Brill A, Fuchs TA, Savchenko AS, Thomas GM, Martinod K, De Meyer SF, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost (2012) 10(1):136-44. doi:10.1111/j.1538-7836.2011.04544.x
17. von Brühl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 209(4):819-35. doi:10.1084/jem.20112322
18. Kambas K, Mitroulis I, Apostolidou E, Girod A, Chrysanthopoulou A, Pneumatikos I, et al. Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One (2012) 7(9):e45427. doi:10.1371/journal.pone.0045427
19. El-Sayed OM, Dewyer NA, Luke CE, Elfline M, Laser A, Hogaboam C, et al. Intact toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice. J Vasc Surg (2015). doi:10.1016/j.jvs.2015.08.070
20. Dewyer NA, El-Sayed OM, Luke CE, Elfline M, Kittan N, Allen R, et al. Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury. Thromb Haemost (2015) 114(5):1028-37. doi:10.1160/TH14-12-1031
21. Gould TJ, Vu TT, Swystun LL, Dwivedi DJ, Mai SH, Weitz JI, et al. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler Thromb Vasc Biol (2014) 34(9):1977-84. doi:10.1161/ATVBAHA.114.304114
22. Kambas K, Mitroulis I, Ritis K. The emerging role of neutrophils in thrombosis-the journey of TF through NETs. Front Immunol (2012) 3:385. doi:10.3389/fimmu.2012.00385
23. Darbousset R, Thomas GM, Mezouar S, Frère C, Bonier R, Mackman N, et al. Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood (2012) 120(10):2133-43. doi:10.1182/blood-2012-06-437772
24. Etulain J, Martinod K, Wong SL, Cifuni SM, Schattner M, Wagner DD. P-selectin promotes neutrophil extracellular trap formation in mice. Blood (2015) 126(2):242-6. doi:10.1182/blood-2015-01-624023
25. Martinod K, Demers M, Fuchs TA, Wong SL, Brill A, Gallant M, et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci U S A (2013) 110(21):8674-9. doi:10.1073/pnas.1301059110
26. Faraday N, Schunke K, Saleem S, Fu J, Wang B, Zhang J, et al. Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils. PLoS One (2013) 8(8):e71447. doi:10.1371/journal.pone.0071447
27. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med (2010) 16(8):887-96. doi:10.1038/nm.2184
28. Martinod K, Witsch T, Farley K, Gallant M, Remold-O'Donnell E, Wagner DD. Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis. J Thromb Haemost (2016) 14(3):551-8. doi:10.1111/jth.13239
29. Petersen LC, Bjorn SE, Nordfang O. Effect of leukocyte proteinases on tissue factor pathway inhibitor. Thromb Haemost (1992) 67(5):537-41.
30. Sreeramkumar V, Adrover JM, Ballesteros I, Cuartero MI, Rossaint J, Bilbao I, et al. Neutrophils scan for activated platelets to initiate inflammation. Science (2014) 346(6214):1234-8. doi:10.1126/science.1256478
31. Maugeri N, Campana L, Gavina M, Covino C, de Metrio M, Panciroli C, et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost (2014) 12(12):2074-88. doi:10.1111/jth.12710
32. Carestia A, Kaufman T, Rivadeneyra L, Landoni VI, Pozner RG, Negrotto S, et al. Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. J Leukoc Biol (2016) 99(1):153-62. doi:10.1189/jlb.3A0415-161R
33. Henke PK, Mitsuya M, Luke CE, Elfline MA, Baldwin JF, Deatrick KB, et al. Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution. Arterioscler Thromb Vasc Biol (2011) 31(1):43-9. doi:10.1161/ATVBAHA.110.216317
34. Beiter T, Fragasso A, Hudemann J, Schild M, Steinacker J, Mooren FC, et al. Neutrophils release extracellular DNA traps in response to exercise. J Appl Physiol (2014) 117(3):325-33. doi:10.1152/japplphysiol.00173.2014
35. de Boer OJ, Li X, Teeling P, Mackaay C, Ploegmakers HJ, van der Loos CM, et al. Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb Haemost (2013) 109(2):290-7. doi:10.1160/TH12-06-0425
36. Swystun LL, Mukherjee S, Liaw PC. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J Thromb Haemost (2011) 9(11):2313-21. doi:10.1111/j.1538-7836.2011.04465.x
37. Carestia A, Rivadeneyra L, Romaniuk MA, Fondevila C, Negrotto S, Schattner M. Functional responses and molecular mechanisms involved in histone-mediated platelet activation. Thromb Haemost (2013) 110(5):1035-45. doi:10.1160/TH13-02-0174
38. Barrientos L, Marin-Esteban V, de Chaisemartin L, Le-Moal VL, Sandré C, Bianchini E, et al. An improved strategy to recover large fragments of functional human neutrophil extracellular traps. Front Immunol (2013) 4:166. doi:10.3389/fimmu.2013.00166
39. de Boer OJ, Li X, Goebel H, van der Wal AC. Nuclear smears observed in H&E-stained thrombus sections are neutrophil extracellular traps. J Clin Pathol (2016) 69(2):181-2. doi:10.1136/jclinpath-2015-203019
40. Diaz JA, Fuchs TA, Jackson TO, Kremer Hovinga JA, Lämmle B, Henke PK, et al. Plasma DNA is elevated in patients with deep vein thrombosis. J Vasc Surg Venous Lymphat Disord (2013) 1(4). doi:10.1016/j.jvsv.2012.12.002
41. Coleman DM, Wakefield TW. Biomarkers for the diagnosis of deep vein thrombosis. Expert Opin Med Diagn (2012) 6(4):253-7. doi:10.1517/17530059.2012.692674
42. van Montfoort ML, Stephan F, Lauw MN, Hutten BA, Van Mierlo GJ, Solati S, et al. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc Biol (2013) 33(1):147-51. doi:10.1161/ATVBAHA.112.300498
43. Savchenko AS, Martinod K, Seidman MA, Wong SL, BorissoffJI, Piazza G, et al. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost (2014) 12(6):860-70. doi:10.1111/jth.12571
44. Zapponi KC, Mazetto BM, Bittar LF, Barnabé A, Santiago-Bassora FD, De Paula EV, et al. Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels. Thromb Res (2014) 133(5):736-42. doi:10.1016/j.thromres.2014.01.035
45. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol (2013) 13(1):34-45. doi:10.1038/nri3345
46. Zinsser HH, Pryde AW. Experimental study of physical factors, including fibrin formation, influencing the spread of fluids and small particles within and from the peritoneal cavity of the dog. Ann Surg (1952) 136(5):818-27. doi:10.1097/00000658-195211000-00006
47. Flick MJ, Du X, Witte DP, Jirousková M, Soloviev DA, Busuttil SJ, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest (2004) 113(11):1596-606. doi:10.1172/JCI20741
48. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 348(16):1546-54. doi:10.1056/NEJMoa022139
49. Dreiher J, Almog Y, Sprung CL, Codish S, Klein M, Einav S, et al. Temporal trends in patient characteristics and survival of intensive care admissions with sepsis: a multicenter analysis. Crit Care Med (2012) 40(3):855-60. doi:10.1097/CCM.0b013e318236f7b8
50. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med (2007) 13(4):463-9. doi:10.1038/nm1565
51. Ma AC, Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost (2008) 6(3):415-20. doi:10.1111/j.1538-7836.2007.02865.x
52. Dwivedi DJ, Toltl LJ, Swystun LL, Pogue J, Liaw KL, Weitz JI, et al. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Critical Care (2012) 16(4):R151. doi:10.1186/cc11466
53. Wildhagen KC, Wiewel MA, Schultz MJ, Horn J, Schrijver R, Reutelingsperger CP, et al. Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients. Thromb Res (2015) 136(3):542-7. doi:10.1016/j.thromres.2015.06.035
54. Varjú I, LongstaffC, Szabó L, Farkas ÁZ, Varga-Szabó VJ, Tanka-Salamon A, et al. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment. Thromb Haemost (2015) 113(6):1289-98. doi:10.1160/TH14-08-0669
55. Mai SH, Khan M, Dwivedi DJ, Ross CA, Zhou J, Gould TJ, et al. Delayed but not early treatment with DNase reduces organ damage and improves outcome in a murine model of sepsis. Shock (2015) 44(2):166-72. doi:10.1097/SHK.0000000000000396
56. Lappann M, Danhof S, Guenther F, Olivares-Florez S, Mordhorst IL, Vogel U. In vitro resistance mechanisms of Neisseria meningitidis against neutrophil extracellular traps. Mol Microbiol (2013) 89(3):433-49. doi:10.1111/mmi.12288
57. Ito T. PAMPs and DAMPs as triggers for DIC. J Intensive Care (2014) 2(1):67. doi:10.1186/s40560-014-0065-0
58. Huang YM, Wang H, Wang C, Chen M, Zhao MH. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps. Arthritis Rheumatol (2015) 67(10):2780-90. doi:10.1002/art.39239
59. Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C, et al. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol (2015) 67(11):2990-3003. doi:10.1002/art.39247
60. Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood (2014) 123(18):2768-76. doi:10.1182/blood-2013-10-463646
61. Xu Z, Huang Y, Mao P, Zhang J, Li Y. Sepsis and ARDS: the dark side of histones. Mediators Inflamm (2015) 2015:205054. doi:10.1155/2015/205054
62. Qian Z, Gelzer-Bell R, Yang Sx SX, Cao W, Ohnishi T, Wasowska BA, et al. Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection. Circulation (2001) 104(19):2369-75. doi:10.1161/hc4401.098471
63. Tarantino E, Amadio P, Squellerio I, Porro B, Sandrini L, Turnu L, et al. Role of thromboxane-dependent platelet activation in venous thrombosis: aspirin effects in mouse model. Pharmacol Res (2016) 107:415-25. doi:10.1016/j.phrs.2016.04.001
64. Coppo P, Froissart A. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange. Hematology Am Soc Hematol Educ Program (2015) 2015:637-43. doi:10.1182/asheducation-2015.1.637
65. Diener JL, Daniel Lagassé HA, Duerschmied D, Merhi Y, Tanguay JF, Hutabarat R, et al. Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779. J Thromb Haemost (2009) 7(7):1155-62. doi:10.1111/j.1538-7836.2009.03459.x
66. Vanhoorelbeke K, Ulrichts H, Van de Walle G, Fontayne A, Deckmyn H, et al. Inhibition of platelet glycoprotein Ib and its antithrombotic potential. Curr Pharm Des (2007) 13(26):2684-97. doi:10.2174/138161207781662867
67. Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood (1996) 88(1):146-57.
68. Thomas MR, Storey RF. Effect of P2Y12 inhibitors on inflammation and immunity. Thromb Haemost (2015) 114(3):490-7. doi:10.1160/TH14-12-1068
69. Krishnamurthy VR, Sardar MY, Ying Y, Song X, Haller C, Dai E, et al. Glycopeptide analogues of PSGL-1 inhibit P-selectin in vitro and in vivo. Nat Commun (2015) 6:6387. doi:10.1038/ncomms7387
70. Ito T, Kawahara K, Okamoto K, Yamada S, Yasuda M, Imaizumi H, et al. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. Arterioscler Thromb Vasc Biol (2008) 28(10):1825-30. doi:10.1161/ATVBAHA.107.150631
71. Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med (2010) 207(9):1853-62. doi:10.1084/jem.20100239
72. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature (2002) 418(6894):191-5. doi:10.1038/nature00858
73. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol (2005) 5(4):331-42. doi:10.1038/nri1594
74. Ito T, Kawahara K, Nakamura T, Yamada S, Nakamura T, Abeyama K, et al. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost (2007) 5(1):109-16. doi:10.1111/j.1538-7836.2006.02255.x
75. Matsushita K, Morrell CN, Cambien B, Yang SX, Yamakuchi M, Bao C, et al. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell (2003) 115(2):139-50. doi:10.1016/S0092-8674(03)00803-1
76. Torisu T, Torisu K, Lee IH, Liu J, Malide D, Combs CA, et al. Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor. Nat Med (2013) 19(10):1281-7. doi:10.1038/nm.3288
77. Schettert IT, Pereira AC, Lopes NH, Hueb WA, Krieger JE. Association between ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease. Thromb Res (2010) 125(1):61-6. doi:10.1016/j.thromres.2009.03.008
78. Villeponteau B. Heparin increases chromatin accessibility by binding the trypsin-sensitive basic residues in histones. Biochem J (1992) 288(Pt 3):953-8. doi:10.1042/bj2880953
79. Napirei M, Ludwig S, Mezrhab J, Klöckl T, Mannherz HG. Murine serum nucleases-contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). FEBS J (2009) 276(4):1059-73. doi:10.1111/j.1742-4658.2008.06849.x
80. Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, et al. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation (2014) 130(13):1062-71. doi:10.1161/CIRCULATIONAHA.114.008828
81. Lapponi MJ, Carestia A, Landoni VI, Rivadeneyra L, Etulain J, Negrotto S, et al. Regulation of neutrophil extracellular trap formation by anti-inflammatory drugs. J Pharmacol Exp Ther (2013) 345(3):430-7. doi:10.1124/jpet.112.202879
82. Oklu R, Albadawi H, Watkins MT, Monestier M, Sillesen M, Wicky S. Detection of extracellular genomic DNA scaffold in human thrombus: implications for the use of deoxyribonuclease enzymes in thrombolysis. J Vasc Interv Radiol (2012) 23(5):712-8. doi:10.1016/j.jvir.2012.01.072
83. LongstaffC, Varjú I, Sótonyi P, Szabó L, Krumrey M, Hoell A, et al. Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones. J Biol Chem (2013) 288(10):6946-56. doi:10.1074/jbc. M112.404301
84. Albadawi H, Oklu R, Raacke Malley RE, O'Keefe RM, Uong TP, Cormier NR, et al. Effect of DNase I treatment and neutrophil depletion on acute limb ischemia-reperfusion injury in mice. J Vasc Surg (2015). doi:10.1016/j.jvs.2015.01.031
85. Ge L, Zhou X, Ji WJ, Lu RY, Zhang Y, Zhang YD, et al. Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy. Am J Physiol Heart Circ Physiol (2015) 308(5):H500-9. doi:10.1152/ajpheart.00381.2014
86. Peer V, Abu Hamad R, Berman S, Efrati S. Renoprotective effects of DNAse-I treatment in a rat model of ischemia/reperfusion-induced acute kidney injury. Am J Nephrol (2016) 43(3):195-205. doi:10.1159/000445546